A judge in Essex County has dismissed New Jersey’s public nuisance claim against Purdue Pharma over its marketing of opioid drug Oxycontin, and ruled several other claims are limited by statute of limitations.

The ruling, issued Oct. 2, leaves intact the state’s claims that Purdue Pharma violated New Jersey’s Consumer Fraud Act by making false or misleading statements and engaged in unconscionable practices, and that it violated the state’s False Claims Act by inducing prescribers to write medically unnecessary prescriptions that the state paid for.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]